We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1055:HKEXKB Financial Group Inc. Analysis

Data as of 2026-03-16 - not real-time

₩149,300.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

KB Financial Group is trading comfortably above its short‑term moving averages, confirming a bullish bias. The relative strength index sits just below the midpoint, indicating neutral momentum without overbought pressure. However, the MACD histogram remains negative, signaling a short‑term bearish tilt that could temper upside near the current price. The forward price‑to‑earnings multiple is well beneath the sector average, suggesting the stock is priced on the cheap side relative to peers. A dividend yield that exceeds the typical market level coupled with a modest payout ratio underscores a sustainable income component. Volatility over the past month is elevated, yet the beta figure is low, meaning the stock’s price swings are largely idiosyncratic rather than market‑driven.
Recent earnings for 2025 revealed a robust increase in net profit, driving a post‑announcement rally of roughly a third. Operating margins are strong and profit margins solid, reflecting robust core profitability. Analysts have a strong‑buy consensus and a median target price notably above the current level, implying notable upside. The fear‑greed index sits in the “greed” zone, reinforcing positive market sentiment toward the stock. Despite a sizable debt balance, the company’s cash reserves and modest payout ratio keep the dividend stream intact. In sum, the combination of undervaluation, solid earnings momentum, and attractive yield makes the stock a compelling candidate for investors with a medium‑ to long‑term horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Negative MACD histogram indicating short‑term pressure
  • Strong dividend yield with low payout ratio
  • Recent earnings beat supporting price stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E well below industry average
  • Robust earnings growth and expanding margins
  • Analyst consensus strong‑buy with upside target

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by cash reserves
  • Low beta indicating limited systematic risk
  • Undervalued valuation relative to peers and growth trajectory

Key Metrics & Analysis

Financial Health

Revenue Growth31.80%
Profit Margin36.72%
P/E Ratio7.9
ROE9.68%
ROA0.75%
Op. Cash Flow₩-18923747540992
Industry P/E16.4

Technical Analysis

TrendBullish
RSI49.3
Support₩132,900.00
Resistance₩172,500.00
MA 20₩156,995.00
MA 50₩143,096.00
MA 200₩122,162.00
MACDBearish
VolumeStable
Fear & Greed Index74.75

Valuation

Target Price₩177,930.00
Upside/Downside19.18%
GradeUndervalued
TypeBlend
Dividend Yield4.31%

Risk Assessment

Beta0.40
Volatility57.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.